SRA's number for the day: 69
This article was originally published in SRA
The European Commission has authorized 69 orphan medicines to date and granted more than 1,000 orphan designations1. The orphan designation permits a company to benefit from the many incentives provided in the EU legislation to develop medicines for rare diseases.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Existing importers and manufacturers of certain medical devices can continue marketing their products for six months or until the Indian medtech regulator makes a final decision on their pending licensing applications.
Differences between how Australia and the EU define “central circulatory system” has resulted in different risk classification levels being assigned to some devices in the two jurisdictions.